?原癌蛋白CBL2抗体Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome.原癌蛋白CBL2抗体 This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. 原癌蛋白CBL2抗体This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia. Mutations in this gene are also the cause of Noonan syndrome-like disorder. [provided by RefSeq, Mar 2012]
Also known as:
C CBL; Cas-Br-M (murine) ecotropic retroviral transforming sequence; Casitas B lineage lymphoma proto oncogene; CBL 2;E3 ubiquitin protein ligase CBL; Oncogene CBL2; Proto oncogene c CBL; RGD1561386; 原癌蛋白CBL2抗体RING finger protein 55; RNF55v Signal transduction protein CBL; 4732447J05Rik; CBL_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CBL2.
●
原癌蛋白CBL2抗体Predicted Molecular Weight: 100kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl469Ra01内皮脂肪酶(LIPG)多克隆抗体Polyclonal Antibody to Likle, Endothelial (LIPG)
kl176Hu01脂肪酶I(LIPI)多克隆抗体Polyclonal Antibody to Likle I (LIPI)
kl176Mu01脂肪酶I(LIPI)多克隆抗体Polyclonal Antibody to Likle I (LIPI)
kl176Ra01脂肪酶I(LIPI)多克隆抗体Polyclonal Antibody to Likle I (LIPI)
kl175Hu01脂肪酶H(LIPH)多克隆抗体Polyclonal Antibody to Likle H (LIPH)
kl175Mu01脂肪酶H(LIPH)多克隆抗体Polyclonal Antibody to Likle H (LIPH)
kl386Hu01脂蛋白脂酶(LIPD)多克隆抗体Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl386Mu01脂蛋白脂酶(LIPD)多克隆抗体Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl386Ra01脂蛋白脂酶(LIPD)多克隆抗体Polyclonal Antibody to Likle, Lipoprotein (LIPD)
kl225Hu01溶酶体酸脂肪酶A(LIPA)多克隆抗体Polyclonal Antibody to Likle A, Lysosomal Acid (LIPA)
kl225Mu01溶酶体酸脂肪酶A(LIPA)多克隆抗体Polyclonal Antibody to Likle A, Lysosomal Acid (LIPA)
kl225Ra01溶酶体酸脂肪酶A(LIPA)多克隆抗体Polyclonal Antibody to Likle A, Lysosomal Acid (LIPA)
kl526Ge01脂多糖(LPS)多克隆抗体Polyclonal Antibody to Lipopolysaccharide (LPS)
kl082Hu01层粘连蛋白γ1(LAMγ1)多克隆抗体Polyclonal Antibody to Laminin Gamma 1 (LAMC1)
kl082Mu01层粘连蛋白γ1(LAMγ1)多克隆抗体Polyclonal Antibody to Laminin Gamma 1 (LAMC1)
kl082Ra01层粘连蛋白γ1(LAMγ1)多克隆抗体Polyclonal Antibody to Laminin Gamma 1 (LAMC1)
kl014Hu01骨成型蛋白4(BMP4)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
kl014Mu01骨成型蛋白4(BMP4)多克隆抗体Polyclonal Antibody to Bone Morphogenetic Protein 4 (BMP4)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话